AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'

Pharmaceutical company AstraZeneca is planning to increase its total revenue by 75% and release 20 new medicines by 2030, including cancer treatments.

May 21, 2024 - 22:00

0 3

AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'

Pharmaceutical company AstraZeneca is planning to increase its total revenue by 75% and release 20 new medicines by 2030, including cancer treatments.

Tags:

Previous Article

AI demand will push the power grid to the brink. Morgan Stanley says these stock...

Short seller alleges Oddity Tech is misleading investors

admin

admin

This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.